Skip to main content

Gynecomastia and Klinefelter Syndrome

Publisher:Open Science Company, LLC
Carol J. Singer-Granick, MD, Tom Reisler, BSc(Hons), MBChB, MRCSEd, and Mark Granick, MD
Gynecomastia and Klinefelter Syndrome
Carol J. Singer-Granick, MD,a Tom Reisler, BSc(Hons), MBChB, MRCSEd,b and Mark Granick, MDb

aDivision of Pediatric Endocrinology, Department of Pediatrics, New Jersey Medical School, Rutgers University, Newark bDivision of Plastic and Reconstructive Surgery, Department of Surgery, New Jersey Medical School, Rutgers University, Newark


Correspondence: mgranickmd@rutgers.edu
Keywords: gynecomastia, Klinefelter syndrome, psychological, surgery, screening

DESCRIPTION

A 22-year-old man with known Klinefelter syndrome desired corrective surgery for gynecomastia. He had had marked gynecomastia with severe skin redundancy (Fig 1) for the past several years. The patient had suffered considerable psychological stress related to his condition. The gynecomastia was treated with simple mastectomies and nipple grafting (Fig 2).

Figure 1. A preoperative photograph of our 22-year-old patient with Klinefelter syndrome demonstrating a grade III gynecomastia.
Figure 2. Postoperative photographs.

QUESTIONS

1. What is the endocrinopathy in Klinefelter syndrome that leads to gynecomastia?

2. What are the psychiatric implications of gynecomastia?

3. What is the differential diagnosis of gynecomastia?

4. What techniques are available for male breast reduction?

DISCUSSION

Klinefelter syndrome is the most common sex chromosomal disorder in males and is caused by a chromosomal abnormality in which 2 or more X chromosomes are present along with a Y chromosome. The most common karyotype is 47XXY. Mosaic karyotypes, such as 46XY/47XXY, can also be seen but with less pronounced clinical features. Klinefelter syndrome occurs in 1:660 men and is the most common cause of chromosomal infertility in males.1 Klinefelter syndrome is usually diagnosed in puberty when the clinical features become most apparent. These include gynecomastia, eunuchoid body proportions, sparse facial and pubertal hair, and small firm testes. Gynecomastia results from a decreased testosterone to estradiol ratio. The seminiferous tubules of the testes hyalinize and fibrose, while adenomatous changes occur in the Leydig cells. This leads to impaired spermatogenesis and testosterone production. Adolescents have low testosterone and elevated gonadotropins (luteinizing hormone and follicle-stimulating hormone). The diagnosis is made by peripheral blood karyotype. The rare instances of mosaicism may require gonadal biopsy for diagnosis. It is important to know that patients with Klinefelter syndrome have an increased risk of breast cancer, as well as mediastinal and retroperitoneal germ cell tumors. Autoimmune disease and diabetes mellitus are more common. Patients with Klinefelter syndrome also have an increased incidence of neurodevelopmental issues and learning disabilities.2

Adult men with gynecomastia have psychological distress associated with the disorder,2 deriving from the significant impact on their lives during adolescence. Adolescents with gynecomastia are frequently affected emotionally and psychologically, regardless of graded severity of disease. Patients have reported embarrassment, humiliation, rejection, and teasing as a result of their breast development. In addition, there are increased feelings of loneliness, restlessness, and tension. There has been a higher association of depression, anxiety, adjustment disorders, low self-esteem, and suicidal ideation.4 It is essential to provide counseling, support, and treatment for all these patients.

Gynecomastia is frequently seen by plastic surgeons in its idiopathic form. However, it is critical for all surgeon who operate on these patients to understand that there is a lengthy and complex list of etiologies and numerous conditions associated with this clinical finding (Tables 1 and 2).5

Table 1. Conditions associated with gynecomastia
Physiological
Neonatal
Pubertal
Involutional
Pathological
Neoplasms
   Testicular
   Pituitary
   Breast tumors
   Adrenal
   Liver
   Human chorionic gonadotropin—ectopic production &
   Lymphoma/leukemia
Endocrinopathies
   Hypogonadism
   Syndrome: Klinefelter, Kallman's
   Androgen insensitivity
   Hermaphroditism
   Enzymatic defects of testosterone synthesis
   Testicular injury/regression
   Hyperthyroidism
   High aromatase
   Adrenal hyperplasia
   Corticotropin deficiency
Chronic illnesses
   Liver disease
   Renal disease
   Malnutrition
   Cystic fibrosis
   AIDS
   Ulcerative colitis
Medications
Table 2. Etiologies of gynecomastia
Idiopathic gynecomastia (no detectable abnormality) 25%
Pubertal gynecomastia 25%
Secondary to medication 10%–20%
Cirrhosis or malnutrition 8%
Primary hypogonadism 8%
Testicular tumors 3%
Secondary hypogonadism 2%
Hyperthyroidism 1.5%
Chronic renal disease 1%

Early intervention and treatment are necessary to improve the negative physical and emotional symptoms. Surgical options for gynecomastia vary due to the amounts of glandular, fibrous, adipose, and skin tissues involved. Liposuction has eliminated the need for skin resection in many patients with gynecomastia, especially adolescents. Fibrous and glandular enlargement can be managed with direct excision through areolar or remote incisions with adjunctive liposuction. However, skin resection is still recommended in patients with grade III gynecomastia6 who have significant ptosis. Procedures such as resection of a concentric circle of skin, pedicled relocation of the nipple with skin resection, or breast amputation with free nipple grafting are options. The treatment of gynecomastia requires an individualized approach.

Gynecomastia is a common clinical finding but has many uncommon etiologies. Klinefelter syndrome is just one of many conditions associated with gynecomastia. Since the diagnosis of Klinefelter syndrome often occurs in puberty, plastic surgeons may be the first physicians in a position to diagnose the disorder. A peripheral blood test for karyotyping and screening of endocrinopathies5 should be performed when additional physical findings suggest the diagnosis. The risk of concomitant breast cancer, germ cell tumors, diabetes, and autoimmune disease must also considered and investigated if indicated.

REFERENCES

1. Groth KA, Skakkebaek A, Host C, Gravholt CH, Bojesen A. Klinefelter syndrome—a clinical update. J Clin Endocrinol Metab. 2013;98:20-30.

2. Paduch DA, Schlegel PN. Male hypogonadism. In: Sarafoglou K, Hoffmann GF, Rith S, eds. Pediatric Endocrinology and Inborn Errors in Metabolism. New York: McGraw Hill Medical; 2009:575-600.

3. Davanço RA, Sabino Neto M, Garcia EB, Matsuoka PK, Huijsmans JP, Ferreira LM. Quality of life in the surgical treatment of gynecomastia. Aesthetic Plast Surg. 2009;33(4):514-7.

4. Nuzzi LC, Cerrato FE, Erickson CR, et al. Psychosocial impact of adolescent gynecomastia: a prospective case-control study. Plast Reconstr Surg. 2013;131(4):890-6.

5. Singer-Granick CJ, Granick MS. Gynecomastia: what a surgeon should know. ePlasty 2009;9:e6. Available at: https://www.eplasty.com/index.php?option=com_content&view=article&id=267&catid=170:volume-09-eplasty-2009. Accessed July 8, 2015.

6. Simon BE, Hoffman S, Kahn S. Classification and surgical correction of gynecomastia. Plast Reconstr Surg. 1973;51:48-52.

JOURNAL INFORMATION ARTICLE INFORMATION
Journal ID: ePlasty Volume: 15
ISSN: 1937-5719 E-location ID: ic61
Publisher: Open Science Company, LLC Published: December 16, 2015